Properties (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
legislation
|
| gptkbp:aimsTo |
public health
|
| gptkbp:amends |
UK_Medicines_Act_1971
UK_Medicines_Act_1981 UK_Medicines_Act_1992 |
| gptkbp:appliesTo |
gptkb:England
gptkb:Northern_Ireland gptkb:Scotland gptkb:Wales |
| gptkbp:defines |
pharmaceuticals
medicinal product controlled drugs |
| gptkbp:enactedBy |
gptkb:Parliament_of_the_United_Kingdom
|
| gptkbp:enforces |
gptkb:MHRA
gptkb:Home_Office |
| gptkbp:established |
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
licensing system for medicines |
| gptkbp:facilitates |
research and development of drugs
|
| https://www.w3.org/2000/01/rdf-schema#label |
UK Medicines Act 1968
|
| gptkbp:includes |
provisions for advertising medicines
provisions for labeling medicines provisions for packaging medicines |
| gptkbp:influences |
EU_regulations_on_medicines
|
| gptkbp:isPartOf |
UK_healthcare_legislation
|
| gptkbp:isRelatedTo |
drug efficacy
patient safety patient rights public health initiatives healthcare quality public health policy drug approval process pharmacovigilance drug safety drug pricing medical ethics drug distribution clinical governance pharmaceutical marketing drug regulation drug safety monitoring clinical trials regulation drug marketing drug research healthcare_access healthcare_funding healthcare_legislation healthcare_compliance healthcare_outcomes healthcare_regulation |
| gptkbp:provides |
penalties for non-compliance
framework for drug approval |
| gptkbp:regulates |
medicinal products
|
| gptkbp:requires |
safety and efficacy data
clinical trials for new medicines |
| gptkbp:supports |
pharmaceutical industry
|
| gptkbp:yearEstablished |
1968-10-01
|